Cornell researchers to launch early trial of gene therapy aimed — ultimately — at preventing Alzheimer's
The notorious difficulty — if not impossibility — of reversing or slowing the progression of Alzheimer’s has pushed researchers to study much earlier stages of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
